William Phillips Ii, MD
Retina Specialist · Bowie, MDNPI 1518931765
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 50.2% of the total. Reporting peaked in 2019 at $299 and has fallen 54.5% since, to $136 in 2025. That places this record below the midpoint for retina specialist clinicians in MD, where the typical reported total is $3,416.
Across 40 payments — averaging $29.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$589
- Genentech USA, Inc.$227
- Apellis Pharmaceuticals, Inc.$151
- Novartis$98
- Regeneron Healthcare Solutions, Inc.$58
- Bausch & Lomb, A Division Of Bausch Health US, LLC$37
- plus $14 from 1 others
What the payments were for
- Food & beverage$1,174100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $589 |
| Genentech USA, Inc. | 6 | $227 |
| Apellis Pharmaceuticals, Inc. | 3 | $151 |
| Novartis | 1 | $98 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $37 |
| Alcon | 1 | $14 |
How this compares
$1,174 in reported general payments places this provider in the 20th percentile of 47 retina specialist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketorolac Tromethamine | 147 | $4,265 |
| Prednisolone Acetate | 62 | $3,770 |
| Bromfenac Sodium | 15 | $1,692 |
| ErythromycinErythromycin Base | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Bowie
- Rohit LakhanpalOwings Mills$168K
- Brian DoChevy Chase$116K
- Adam GerstenblithHagerstown$107K
- Aziz KhanifarSilver Spring$83K
- Michael ElmanBaltimore$27K
- Reginald SandersGreenbelt$24K
- Sidney SchechetBaltimore$23K
- Mohsin AliGreenbelt$14K
- Michael LaiChevy Chase$13K
- Robert ParnesHagerstown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.